COVID-19 Vaccine Janssen (Ad26.COV2-S [recombinant]) 0.5ml dose suspension for injection multidose v...

ID 39230211000001104
ConceptGeneric COVID-19 Vaccine Janssen (Ad26.COV2-S [recombinant]) 0.5ml dose suspension for injection multidose vials
Name COVID-19 Vaccine Janssen (Ad26.COV2-S [recombinant]) 0.5ml dose suspension for injection multidose vials
Abbreviated name COVID-19 Vaccine Janssen 0.5ml inj multidose vials
Description COVID-19 Vaccine Janssen (Ad26.COV2-S [recombinant]) 0.5ml dose suspension for injection multidose vials (Janssen-Cilag Ltd)
Date of name applicability 1 Sep 2021
Previous Name COVID-19 Vaccine Janssen (Ad26.COV2-S [recombinant]) 0.5ml dose solution for injection multidose vials
SupplierJanssen-Cilag Ltd
Licensed asMedicines - MHRA/EMA
Previously licensed asNone
License change reasonLicence Granted
Date of change of licensing authority 24 Nov 2021
EMA (European Medicines Agency) Monitoring 1
Restrictions on availabilityRestricted Availability
Licensed routeIntramuscular